Media hype about medical innovations tends to focus on new therapies emerging from laboratories and clinical trials. Sadly, many breakthroughs fail to achieve optimal results in the real world, for reasons ranging from poor adherence by their patients, to drug formulations that may bias against atypical users, from children to people with stroke.